PTPκ Inhibitors are a class of chemical compounds that target and inhibit the activity of protein tyrosine phosphatase kappa (PTPκ), an enzyme belonging to the protein tyrosine phosphatase (PTP) family. PTPκ is a transmembrane receptor-type phosphatase that plays a critical role in cellular signaling pathways by dephosphorylating specific tyrosine residues on target proteins. This dephosphorylation process is essential for regulating various cellular functions, including cell adhesion, migration, and signaling cascades involved in cell growth and differentiation. PTPκ is particularly noted for its involvement in the regulation of cadherin-mediated cell-cell adhesion, a fundamental process in maintaining tissue architecture and integrity.
The use of PTPκ Inhibitors in research allows scientists to investigate the complex signaling networks that PTPκ influences, particularly those related to cell-cell communication and the maintenance of epithelial cell integrity. By inhibiting PTPκ activity, researchers can explore the downstream effects on cadherin-mediated adhesion and how disruptions in this process can affect cellular behavior. These inhibitors are valuable tools for studying the dynamics of cell adhesion molecules and their role in tissue morphogenesis, wound healing, and cellular response to environmental changes. Additionally, PTPκ Inhibitors provide insights into the broader regulatory mechanisms of tyrosine phosphorylation and dephosphorylation in cellular signaling networks, offering a deeper understanding of how cells coordinate their functions and maintain homeostasis. Overall, PTPκ Inhibitors are critical for advancing knowledge in cell biology, particularly in areas related to cell adhesion, signaling, and the intricate balance of phosphorylation states that govern cellular processes.
Items 1 to 10 of 16 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Inhibit PTPR activity by binding to its active site, preventing its enzymatic activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Blocks PTPR phosphorylation and activation, reducing its signaling function. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
Inhibits PTPR activity by binding to its kinase domain, preventing autophosphorylation. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $172.00 $964.00 | 2 | |
Targets PTPR and other kinases, suppressing their activation and downstream signaling. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Interferes with PTPR signaling by inhibiting its phosphorylation and activation. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Disrupts PTPR-mediated signaling cascades by inhibiting its kinase domain. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | $320.00 $430.00 | 3 | |
Suppresses PTPR activity by blocking its kinase domain, hindering downstream effects. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
Targets PTPR and other kinases, impairing their signaling functions. | ||||||
Acalabrutinib | 1420477-60-6 | sc-507392 | 250 mg | $255.00 | ||
Inhibits PTPR signaling by binding to its kinase domain and preventing activation. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
A known non-specific inhibitor of protein tyrosine phosphatases, which can inhibit PTPR activity by mimicking the transition state of the enzyme′s substrate. | ||||||